Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 22
Filtrar
Más filtros

Bases de datos
País/Región como asunto
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Hum Reprod ; 29(3): 548-54, 2014 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-24327538

RESUMEN

STUDY QUESTION: Does in vivo exposure to benzo(a)pyrene (BaP) induce DNA damage in oocytes and cumulus cells (CCs) in mice? SUMMARY ANSWER: Significant increases in DNA strand breaks in oocytes and CCs and in BaP-induced DNA adducts in CCs were detected in exposed mice compared with controls. WHAT IS KNOWN ALREADY: BaP has well-known mutagenic and carcinogenic effects on somatic cells, and is also registered as potential reproductive toxicant by several environmental protection agencies. It has been shown to cause a significant increase in DNA adducts in ovarian tissues; however, to our knowledge, the genotoxic effects of BaP on oocytes and CCs have not been studied to date. STUDY DESIGN, SIZE, DURATION: Female CD1 mice were exposed to BaP via the oral administration of a single dose of 13 mg/kg body weight (bw); matched controls were exposed to the vehicle only (soya oil). A total of 15 groups of 6 mice (exposed or controls) were sacrificed 2, 4, 6, 15 or 22 days after BaP exposure, and after collection of oviducts, the oocyte-CC complexes (COC) were released. PARTICIPANTS/MATERIALS, SETTING, METHODS: The alkaline comet assay was used to quantify the DNA breaks in oocytes and CCs; DNA damage was expressed as the Olive Tail Moment (OTM). Immunofluorescent staining was used to quantify BaP-induced DNA adducts in CCs. Fluorescence was expressed as the average grey value (AGVA; arbitrary units). The differences between the exposed and control groups were assessed using analysis of variance (ANOVA) and the non-parametric Mann-Whitney test. MAIN RESULTS AND THE ROLE OF CHANCE: Higher levels of DNA damage were observed in the oocytes and CCs of BaP-exposed mice than in those of vehicle controls. Significant increases in OTM (mean ± SE) were detected in (i) oocytes from females exposed for 4 (10.5 ± 0.9 versus 3.1 ± 0.4, P < 0.0001) or 6 days before collection (15.6 ± 2.0 versus 3.6 ± 0.9, P < 0.0001) and (ii) CCs from females exposed 2 (6.4 ± 0.6 versus 2.1 ± 0.2, P < 0.0001), 4 (7.8 ± 0.4 versus 2.4 ± 0.1, P < 0.0001) or 6 days before collection (7.3 ± 0.3 versus 3.2 ± 0.5, P < 0.0001) compared with controls. A significant increase in benzo(a)pyrene-7,8-9,10 diol epoxide (BPDE)-DNA adducts and higher AGVA (mean ± SE) scores were observed in CCs from females exposed 2 (6.1 ± 0.3 versus 3.6 ± 0.5, P < 0.0001), 4 (7.5 ± 0.1 versus 3.4 ± 0.1, P < 0.0001) or 6 days before collection (11.6 ± 0.4 versus 3.7 ± 0.1, P < 0.0001) compared with control mice. LIMITATIONS, REASONS FOR CAUTION: Mice were given one treatment via the oral route because this dose and mode of administration have been shown to induce detectable BPDE-DNA adduct levels in mouse organs and sperm cells. Additional data are needed to assess DNA damage in oocytes and CCs after chronic exposure to BaP in vivo. WIDER IMPLICATIONS OF THE FINDINGS: To our knowledge, this is the first study examining the in vivo genotoxicity of BaP in oocytes and CCs. We observed significant DNA damage in the oocytes and CCs of mice after acute BaP exposure. BPDE-DNA adducts result directly from BaP metabolism while DNA breaks could result mainly from BPDE-DNA adduct excision and repair and/or through direct genotoxicity from increased reactive oxygen species. These results add new and important insights regarding the recently suggested toxicity of chronic BaP exposure in the ovary. STUDY FUNDING/COMPETING INTEREST(S): This work was supported by a grant (93-CPQ 2012-05) from the DIRRECTE, Provence Alpes Côte d'Azur, France. None of the authors have any conflict of interest to declare.


Asunto(s)
Benzo(a)pireno/toxicidad , Células del Cúmulo/efectos de los fármacos , Daño del ADN , Oocitos/efectos de los fármacos , 7,8-Dihidro-7,8-dihidroxibenzo(a)pireno 9,10-óxido/metabolismo , Animales , Benzo(a)pireno/química , Aductos de ADN/química , Aductos de ADN/metabolismo , Femenino , Ratones
2.
J Clin Endocrinol Metab ; 65(6): 1112-7, 1987 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-3680478

RESUMEN

This study was undertaken to investigate the role of GH secretion in the pubertal increase in plasma somatomedin-C (Sm-C) concentrations and its relation to growth in children with true precocious puberty (PP) and normal or deficient GH secretion. We studied 37 children (9 boys and 28 girls), divided into 3 groups according to their pubertal stages and their peak stimulated plasma GH concentration. Group I (n = 20) contained patients with PP and normal GH secretion. In group II (n = 8), PP was accompanied by GH deficiency. Group III (n = 9) patients were GH deficient and prepubertal. The mean plasma Sm-C (RIA) levels in groups I and II were 2.01 +/- 0.17 (+/- SEM) and 0.59 +/- 0.21 U/mL, respectively (P less than 0.001), and it was 0.09 +/- 0.01 U/mL in group III (P less than 0.001 compared to group II). The higher mean plasma Sm-C level in group II compared to that in group III could be related to a significantly higher GH response to arginine-insulin stimulation (P less than 0.02), although this value was in the hypopituitary range. The mean growth rate in group II (6.8 +/- 0.9 cm/yr) was also much higher than the rate in group III (1.9 +/- 0.5 cm/yr; P less than 0.001) and only slightly lower than that in group I (90 +/- 0.8 cm/yr; P less than 0.05). These data indicate that plasma Sm-C values are closely correlated with even small changes in GH secretion. The observed growth rates could, in general, be linked to plasma GH and Sm-C levels, as modulated by sex steroids, in these patients with precocious puberty.


Asunto(s)
Hormona del Crecimiento/metabolismo , Crecimiento , Factor I del Crecimiento Similar a la Insulina/sangre , Pubertad Precoz/fisiopatología , Somatomedinas/sangre , Adolescente , Estatura , Niño , Preescolar , Femenino , Hormonas Esteroides Gonadales/fisiología , Hormona del Crecimiento/sangre , Humanos , Masculino
3.
J Clin Endocrinol Metab ; 76(1): 248-50, 1993 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-7678425

RESUMEN

In Laron-type dwarfism, a basal growth rate independent of GH and insulin-like growth factor-I (IGF-I) is maintained. This represents a unique model to further assess the relationship between growth and nutritional status. In a child aged 3 yr, 7 months with severe anorexia, growth was followed in relation to his caloric intake. While receiving 496 Cal/day with 11.6 g/day protein, he grew at a rate of 2 cm/yr (period I). The mean plasma IGF-I level was below 0.07 U/mL, insulin was 3.8 +/- 0.2 microU/mL, and blood glucose was 2.9 +/- 0.3 mM/L. During moderate hyperalimentation with 1280 Cal/day and 38.3 g/day protein (period II) for 7 months, growth rate increased to 9 cm/yr with no significant change in plasma IGF-I and persistence of relative hypoinsulinemia (low response to oral glucose tolerance test). IGF-binding proteins, analyzed by Western ligand blotting, showed that 41.5- and 38.5-kilodalton forms, which were initially low, increased to form a pattern similar to that observed in hypopituitarism. These results suggest that catch-up growth did not require normal circulating GH and/or IGF-I activity. Therefore, nutrition contributes to catch-up growth and achievement of potential statural growth by a distinct cellular effect.


Asunto(s)
Proteínas Portadoras/sangre , Enanismo/fisiopatología , Crecimiento , Factor I del Crecimiento Similar a la Insulina/metabolismo , Glucemia/metabolismo , Proteínas Portadoras/aislamiento & purificación , Preescolar , Proteínas en la Dieta , Enanismo/sangre , Enanismo/dietoterapia , Ingestión de Energía , Hormona del Crecimiento/sangre , Humanos , Insulina/sangre , Proteínas de Unión a Factor de Crecimiento Similar a la Insulina , Masculino
4.
J Clin Endocrinol Metab ; 40(3): 534-6, 1975 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-1117062

RESUMEN

In neonates, plasma somatomedin as measured by the porcine cartilage assay was very low during the first day of life. A striking increase was observed on day 4 and 5, with a return to lower values at a later age. These findings indicate an early capacity to generate somatomedin activity in newborns.


Asunto(s)
Recién Nacido , Somatomedinas/análisis , Bioensayo , Sangre , Femenino , Humanos , Embarazo , Cordón Umbilical
5.
J Clin Endocrinol Metab ; 68(2): 346-51, 1989 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-2645307

RESUMEN

Although GH deficiency (GHD) is the most frequent hormonal abnormality that occurs after cranial radiation, the natural course of this complication and its relationship to growth in children are not known. Therefore, we undertook a 2-yr prospective study of 16 children, aged 1.7-15 yr at the time of treatment, who received cranial [31-42 Gy (1 Gy = 100 rads)] and spinal radiation for medulloblastoma or ependymoma (group I). Their growth was compared to that of 11 children given similar doses of cranial radiation only (group II). The mean plasma GH response to arginine-insulin test (AITT) was 9.1 +/- 1.5 (+/- SE) micrograms/L in group I and 8.5 +/- 1.8 micrograms/L in group II (P = NS). After 2 yr, 16 of the 27 children had a peak plasma GH value below 8 micrograms/L after AITT, and 10 children had a peak response less than 5 micrograms/L. In addition, in group I, AITT and sleep-related GH secretion were compared; at the 2 yr follow-up only 3 of 13 children had discrepant results. At the 2 yr follow-up children treated by cranial and spinal radiation had a mean height of -1.46 +/- 0.40 SD below the normal mean. In contrast, the children given only cranial radiation had a mean height of -0.15 +/- 0.18 SD; P less than 0.02. Therefore, most of the growth retardation appeared to be due to lack of spinal growth. GHD is thus an early complication of cranial radiation in these children, and no significant growth retardation can be attributed to GHD during the first 2 yr. These data contribute to the organization of follow-up in irradiated children in order to decide when human GH treatment is necessary.


Asunto(s)
Neoplasias Encefálicas/radioterapia , Trastornos del Crecimiento/etiología , Hormona del Crecimiento/deficiencia , Hipotálamo/efectos de la radiación , Hipófisis/efectos de la radiación , Adolescente , Factores de Edad , Neoplasias Cerebelosas/radioterapia , Ependimoma/radioterapia , Femenino , Hormona del Crecimiento/sangre , Humanos , Insulina/administración & dosificación , Insulina/análogos & derivados , Factor I del Crecimiento Similar a la Insulina/sangre , Masculino , Meduloblastoma/radioterapia , Hipófisis/metabolismo , Neoplasias de la Columna Vertebral/radioterapia , Factores de Tiempo
6.
Biotechniques ; 26(3): 536-40, 1999 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-10090997

RESUMEN

Numerous cell-based or cell-free systems for study of selectin adhesion use radiolabeled tracers. However, in addition to handling problems associated with the use of radioisotopes, these assays have difficulty relating a number of counts to a number of adherent cells. Here, we describe an assay that uses the natural fluorescence of the green fluorescent protein (GFP) to measure binding of cells to E-selectin. We elaborated an adhesion system composed of a cell monolayer expressing E-selectin ligand to which monodispersed fluorescent Chinese hamster ovary (CHO) cells expressing E-selectin are added. Due to GFP autofluorescence, adhered cells can be easily distinguished from cell monolayers by fluorescence microscopy, and adhesion can be measured by cytofluorometry. We applied this GFP-based adhesion assay to measure the adherence of a pancreatic tumor cell line and found that the binding parameters of these cells satisfy a number of E-selectin-specific criteria.


Asunto(s)
Selectina E/análisis , Proteínas Luminiscentes/genética , Animales , Anticuerpos Monoclonales/inmunología , Anticuerpos Monoclonales/farmacología , Células CHO , Adhesión Celular/efectos de los fármacos , Adhesión Celular/genética , Comunicación Celular/efectos de los fármacos , Comunicación Celular/genética , Quelantes/farmacología , Cricetinae , Selectina E/genética , Selectina E/inmunología , Ácido Egtácico/farmacología , Expresión Génica , Proteínas Fluorescentes Verdes , Humanos , Proteínas Recombinantes de Fusión/análisis , Proteínas Recombinantes de Fusión/genética , Sensibilidad y Especificidad , Transfección , Células Tumorales Cultivadas
7.
Biochem Pharmacol ; 60(11): 1579-84, 2000 Dec 01.
Artículo en Inglés | MEDLINE | ID: mdl-11077039

RESUMEN

Antimicrotubule agent-induced apoptosis was examined in the proliferating human colon cancer cell line HT29-D4. G2/M arrest and subsequent apoptosis were dose-dependent, both observed with 100 nM paclitaxel or docetaxel and 10 nM vinorelbine. Bcl-x(L) phosphorylation was observed simultaneously with mitotic block, then caspase-3 cleavage and poly(ADP-ribose) polymerase degradation were detected 48 hr later. By using both enzymatic assay and immunoblot detection of cleaved fragments, we showed that caspase-8, a central component of the CD95-induced apoptotic pathway, was significantly activated during paclitaxel exposure, contemporary to apoptosis occurrence. Caspase-8 activation and apoptosis were independent of CD95 ligation and evidenced only for concentrations inducing Bcl-x(L) phosphorylation and a decrease in mitochondria permeability. Similar results were obtained with docetaxel and vinca alkaloids. Thus, antimitotic drugs may induce apoptosis via caspase-8 activation independently of CD95/CD95-L. Caspase-8 may be a common mediator of anticancer drug-induced apoptosis that could represent a promising target for future therapies.


Asunto(s)
Antineoplásicos Fitogénicos/farmacología , Apoptosis , Caspasas/metabolismo , Glicoproteínas de Membrana/metabolismo , Paclitaxel/farmacología , Receptor fas/metabolismo , Caspasa 8 , Caspasa 9 , Neoplasias del Colon , Activación Enzimática , Proteína Ligando Fas , Células HT29 , Humanos , Mitocondrias/efectos de los fármacos , Mitocondrias/fisiología , Mitosis/efectos de los fármacos , Fosforilación , Proteínas Proto-Oncogénicas c-bcl-2/metabolismo , Proteína bcl-X
8.
Eur J Clin Nutr ; 46(2): 137-42, 1992 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-1559516

RESUMEN

The purpose of this study was to assess the validity of insulin-like growth factor (IGFI) determination as an index of nutritional status and growth in Equadorian schoolboys. Plasma IGFI was measured in 144 healthy boys, 9 years old, who were classified by their social class in four groups: 1 (n = 29); 2 (n = 49); 3 (n = 28); 4 (n = 8). Children in groups 1 and 2, of the lower socio-economic class, had significantly reduced caloric and protein intakes compared to children in groups 3 and 4 (P less than 0.01). Mean heights were significantly lower in groups 1 and 2 (P less than 0.001 and less than 0.05, respectively). The mean plasma IGFI in group 1 was 561 +/- 64 mU/ml and significantly lower than that in groups 2-4 (872 +/- 75, 986 +/- 94, and 1238 +/- 190 mU/ml in groups 2, 3 and 4, respectively) (P less than 0.01). The effect of caloric and nitrogen supplementation was studied in 36 children taken from groups 1 and 2 combined, and divided into three subgroups; they were given (1) an animal protein supplement of 18 g/day with 860 kcal/day (n = 12), (2) a vegetable protein supplement of 17.8 g/day based on a traditional Andean food with 862 kcal/day (n = 12), and (3) a placebo (n = 12). The IGFI levels increased significantly after 7 and 14 days in both subgroups 1 and 2. These results demonstrate that plasma IGFI reflects the nutritional status and responds to a short-term diet supplementation. It may provide a reliable means of assessing the effect of nutritional programs intended to improve the growth of children in underdeveloped countries.


Asunto(s)
Estatura , Dieta , Factor I del Crecimiento Similar a la Insulina/análisis , Clase Social , Niño , Proteínas en la Dieta , Ecuador , Ingestión de Energía , Alimentos Fortificados , Crecimiento , Humanos , Masculino , Estado Nutricional
9.
Water Sci Technol ; 44(5): 161-9, 2001.
Artículo en Inglés | MEDLINE | ID: mdl-11695455

RESUMEN

Wet oxidation in subcritical conditions is a new alternative to usual routes for sewage sludge treatment and it complies with environmental standards. The paper presents tests carried out on a batch reactor and on a continuous pilot unit, treating municipal sewage sludge. A method is proposed that shows that the oxidation efficiency in a continuous reactor can only be easily predicted from the residence time distribution and batch tests results. Nevertheless, a partial settling of the solid residue in the continuous bubble column reactor is evident, and it increases the solid residence time and then decreases its organic content with respect to a similar batch test. In addition, these results highlight the considerable influence of temperature in the oxidation reactor and of the type of sewage sludge which is treated. At temperatures around 240 degrees C, foaming can seriously impair the operation of the continuous reactor, because of the presence of non-degraded fatty compounds and surfactants. Moreover, the COD reduction is limited to 70%. On the contrary, at 300 degrees C, COD removal efficiency greater than 80% is achieved without any catalyst additive and, in addition, only highly biodegradable compounds remain in the oxidised liquor.


Asunto(s)
Aguas del Alcantarillado/química , Eliminación de Residuos Líquidos/métodos , Purificación del Agua/métodos , Grasas , Oxidación-Reducción , Oxígeno/química , Temperatura , Movimientos del Agua
10.
Water Sci Technol ; 44(10): 163-9, 2001.
Artículo en Inglés | MEDLINE | ID: mdl-11794648

RESUMEN

Wet oxidation (WO) in subcritical conditions is a new alternative to usual routes for sewage sludge treatment that complies with environmental standards. This paper presents tests carried out using a batch reactor and continuous pilot and industrial units, treating municipal sewage sludge. The main products after oxidation are CO2, water, VFA and ammonia. The results highlight the considerable influence of the treatment temperature and of the type of sewage sludge which is treated. At temperatures around 240 degrees C, VFA fraction present in WO supernatant is limited to 50% because of the presence of non-degraded fatty compounds and surfactants. Moreover, the COD reduction is limited to 70%. On the contrary, at 300 degrees C, COD removal efficiencies greater than 80% are achieved without any catalyst addition and, in addition, only highly biodegradable compounds remain in the oxidised liquor. In order to treat the residual ammonia nitrogen by biological processes, it is therefore necessary to obtain a VFA fraction as high as possible for achieving denitrification and then to operate the WO process at high temperature and without catalyst addition.


Asunto(s)
Amoníaco/análisis , Nitrógeno/análisis , Aguas del Alcantarillado/química , Eliminación de Residuos Líquidos/métodos , Amoníaco/química , Reactores Biológicos , Dióxido de Carbono/análisis , Catálisis , Nitrógeno/metabolismo , Oxidación-Reducción , Temperatura , Agua/análisis
12.
Acta Paediatr Scand ; 69(1): 37-41, 1980 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-6989150

RESUMEN

Anorexia nervosa in childhood and adolescence, associated with impaired growth can be considered as a form of chronic malnutrition. Twelve patients aged 11 to 17 years were investigated. In spite of increased GH secretion, plasma somatomedin activities were diminished in 8 cases. Plasma T4, T3 and arginine stimulated insulin secretion were also decreased. In six patients who gained weight a significant negative correlation was found between weight deficit and plasma somatomedin activity. Prolonged administration of growth hormone in one case did not stimulate the generation of somatomedin activity. Nutrition and increased insulin secretion could plan a role in changes observed during recovery.


Asunto(s)
Anorexia Nerviosa/fisiopatología , Hormona del Crecimiento/metabolismo , Somatomedinas/sangre , Adolescente , Anorexia Nerviosa/sangre , Peso Corporal , Niño , Femenino , Hormona del Crecimiento/sangre , Humanos , Insulina/metabolismo , Secreción de Insulina , Masculino , Tiroxina/sangre , Triyodotironina/sangre
13.
Artículo en Inglés | MEDLINE | ID: mdl-3465160

RESUMEN

In a large group of 74 patients irradiated with 2400 rad for acute lymphoblastic leukemia an unusually high frequency of complete GH deficiency was observed (40%). Only 11 out of 46 prepubertal children had growth retardation and seven children received hGH treatment. On the contrary 11 other prepubertal cases had normal growth rates in spite of lack of response to AITT. Plasma SmC values were correlated with growth rates but were discrepant with GH responses to AITT in some cases. Because of this high frequency of GH dysregulation further growth at time of puberty should be carefully documented.


Asunto(s)
Encéfalo/efectos de la radiación , Hormona del Crecimiento/deficiencia , Factor I del Crecimiento Similar a la Insulina/sangre , Leucemia Linfoide/radioterapia , Traumatismos por Radiación/complicaciones , Somatomedinas/sangre , Estatura , Niño , Femenino , Trastornos del Crecimiento/etiología , Hormona del Crecimiento/metabolismo , Hormona del Crecimiento/uso terapéutico , Humanos , Masculino , Pubertad/fisiología
14.
Arch Dis Child ; 64(8): 1170-6, 1989 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-2782932

RESUMEN

An attempt was made to identify the less severe cases of precocious puberty and to describe their natural course. A group of 17 girls with precocious puberty and a bone age advance over chronological age of less than two years (group 1) was compared with a group of 19 patients with severe precocious puberty and bone age advance of two years or more (group 2). Mean (SEM) plasma oestradiol concentrations were 82 (30) pmol/l and 164 (21) pmol/l (p less than 0.05), vaginal maturation indexes were 16 (5) and 41 (4), and plasma somatomedin C concentrations were 1.0 (0.2) U/ml (n = 8) and 2.1 (0.3) U/ml (n = 16) in groups 1 and 2, respectively. The time between onset and diagnosis of secondary sexual characteristics was about one year in both groups. After two years' follow up the untreated patients in group 1 had maintained their predicted final height. These changes were in contrast to those observed at first examination in patients in group 2 who had a mean (SD) predicted final height of -1.3 (0.2) and a mean bone age advance of 3.0 (0.2) years. These data show that bone age advance to chronological age, and plasma somatomedin C concentrations measured at initial evaluation are helpful in identifying less severe and potentially slow progressing forms of central precocious puberty.


Asunto(s)
Determinación de la Edad por el Esqueleto , Pubertad Precoz/fisiopatología , Estatura , Mama/crecimiento & desarrollo , Niño , Preescolar , Estradiol/sangre , Femenino , Estudios de Seguimiento , Humanos , Factor I del Crecimiento Similar a la Insulina/sangre , Pronóstico , Pubertad Precoz/sangre , Pubertad Precoz/diagnóstico
15.
Br J Exp Pathol ; 68(2): 145-56, 1987 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-3107608

RESUMEN

This study demonstrates that cytolytic T-cell lines exhibit progressive in-vitro modifications of their phenotype and of their growth behaviour and may use different pathways for their multiplication. Comparing three established cell lines, we firstly demonstrated that the expression of LFA-I is stable but the Lyt 2, 3 is rapidly lost. In this case, a high lectin-dependent cytotoxicity appears. Secondly, we demonstrated that two of the cell lines used the interleukin 2-interleukin 2 receptors (IL-2-IL-2R) binding pathway. Two different monoclonal antibodies showed that the IL-2 receptors distribution does not correlate with the number of functional sites which determines the IL-2 requirement. In contrast, the third cell line, although bearing high levels of IL-2 receptors, grows without the addition of IL-2; this cell growth is not inhibited by anti-IL-2 receptors monoclonal antibodies. Thirdly, it appears that the new property of IL-2 independence is associated with acquisition of the simultaneous capacity to induce tumour grafts in nude mice. As it has been recently reported that cytolytic T-lymphocytes against tumour cells could be promising immunotherapeutic agents, the spontaneous malignant transformation of such CTL lines should be taken into account before using them for adoptive immunotherapeutic purposes.


Asunto(s)
Linfocitos T Citotóxicos/inmunología , Animales , Antígenos de Diferenciación de Linfocitos T , Antígenos de Superficie/análisis , Diferenciación Celular , Línea Celular , Supervivencia Celular , Gránulos Citoplasmáticos/ultraestructura , Citotoxicidad Inmunológica , Femenino , Interleucina-2/análisis , Masculino , Ratones , Ratones Endogámicos , Mitosis , Fenotipo , Linfocitos T/ultraestructura
16.
Arch Fr Pediatr ; 36(9 Suppl): XIII-XVIII, 1979 Nov.
Artículo en Francés | MEDLINE | ID: mdl-539880

RESUMEN

Sixteen children, aged 5-19 years with late diagnosed coeliac disease who presented with significant growth delay were studied. Plasma somatomedin was decreased in all patients (mean 0.28 +/- 0.1) but the circulating growth hormone levels were normal in 12 patients. No inhibitory activity could be detected. Somatomedin activity was partially corrected in six patients who were re-examined after 3 months on a gluten free diet. This suggests that low somatomedin levels may be the result of the nutritional abnormalities during the active phase of the disease.


Asunto(s)
Enfermedad Celíaca/sangre , Hormona del Crecimiento/metabolismo , Somatomedinas/sangre , Adolescente , Adulto , Enfermedad Celíaca/complicaciones , Enfermedad Celíaca/dietoterapia , Niño , Femenino , Glútenes/administración & dosificación , Trastornos del Crecimiento/etiología , Humanos , Masculino
17.
Arch Fr Pediatr ; 37(8): 515-9, 1980 Oct.
Artículo en Francés | MEDLINE | ID: mdl-7447606

RESUMEN

Somatomedin activity, as estimated by the porcine bioassay and GH response to stimulation were compared in prepubertal children with severe growth retardation and lack of evidence of pituitary dysfunction. Somatomedin activity was strongly correlated with growth rate. A group of patients had a low somatomedin activity in contrast with normal GH responsiveness. This appears to be a rather frequent situation and deserves further evaluation of the somatomedin system and a more critical approach of GH secretion.


Asunto(s)
Trastornos del Crecimiento/sangre , Hormona del Crecimiento/sangre , Somatomedinas/sangre , Adolescente , Niño , Preescolar , Femenino , Crecimiento , Trastornos del Crecimiento/fisiopatología , Humanos , Masculino
18.
Horm Res ; 36(3-4): 116-20, 1991.
Artículo en Inglés | MEDLINE | ID: mdl-1818007

RESUMEN

Girls suffering from idiopathic central precocious puberty (CPP) may have different levels of estrogenic activity. This study was performed to evaluate the relationship between the estrogenic activity and the hypothalamopituitary activation and the effect of various plasma estradiol (E2) levels on growth, skeletal maturation and plasma insulin-like growth factor I (IGF-I). Fifty-eight girls with CPP were divided into 2 groups: group I with E2 less than 25 pg/ml (13 +/- 1 pg/ml, mean +/- SEM, n = 26) and group II with E2 greater than or equal to 25 pg/ml (52 +/- 3 pg/ml, n = 32). The mean ages at onset and at evaluation were lower in group I (5.9 +/- 0.4 and 6.8 +/- 0.4 years) than in group II (6.8 +/- 0.3 and 8.1 +/- 0.2 years, p less than 0.01), but the durations since onset (greater than 0.5 and less than 2 years) in the two groups were similar. The mean peak luteinizing hormone/follicle-stimulating hormone (LH/FSH) ratios were lower in group I (0.8 +/- 0.2) than in group II (1.7 +/- 0.2, p less than 0.001) and correlated with E2 (r = 0.41, p less than 0.01). The mean height gains during the year preceding the initial evaluation were similar in the two groups (8.7 +/- 0.5 vs. 9.2 +/- 0.4 cm). They were independent of the plasma E2 level. Conversely, the mean plasma IGF-I values were lower in group I (2.4 +/- 0.3 U/ml) than in group II (4.2 +/- 0.6 U/ml, p less than 0.01) and correlated with E2 (r = 0.52, p less than 0.01).(ABSTRACT TRUNCATED AT 250 WORDS)


Asunto(s)
Desarrollo Óseo/fisiología , Estradiol/sangre , Crecimiento/fisiología , Factor I del Crecimiento Similar a la Insulina/metabolismo , Pubertad Precoz/fisiopatología , Niño , Preescolar , Femenino , Hormona Folículo Estimulante/sangre , Humanos , Hormona Luteinizante/sangre
19.
Reprod Nutr Dev (1980) ; 28(2A): 233-40, 1988.
Artículo en Francés | MEDLINE | ID: mdl-3375573

RESUMEN

This study concerns the immunoreactive somatomedin C secretion by prepubertal rabbit epiphyseal chondrocytes cultured in a defined serum-free medium. In such culture conditions, chondrocytes mainly synthesized Type II collagen (80% of total collagen) during 10 days. A small amount of Type I collagen was also found with a significant (p less than 0.05) higher level during the period of cell multiplication (6.4 +/- 1.5%) than when cells reached confluency (0.9 +/- 0.2%). During the 10 days of culture without serum and without hormone added, a Sm-C/IGF1 activity was measured by RIA at a mean level of 30 +/- 5 mU/ml/10 micrograms DNA. This value was significantly higher (p less than 0.001) than in the medium not incubated with the cells (1.7 +/- 0.9 mU/ml). When hGH was added to the culture medium during the period of cell division, the level of Sm-C/IGF1 activity was significantly elevated at 39 +/- 4 mU/ml/10 micrograms DNA (p less than 0.05) and at 55 +/- 3 mU/ml/10 micrograms DNA (p less than 0.001) with 50 ng/ml and 100 ng/ml hGH concentrations respectively. On the contrary, no difference was observed at confluency in treated and non treated cells.


Asunto(s)
Hormona del Crecimiento/farmacología , Placa de Crecimiento/citología , Factor I del Crecimiento Similar a la Insulina/metabolismo , Somatomedinas/metabolismo , Animales , Diferenciación Celular/efectos de los fármacos , Células Cultivadas , Colágeno/biosíntesis , Placa de Crecimiento/efectos de los fármacos , Placa de Crecimiento/metabolismo , Masculino , Conejos , Maduración Sexual
20.
Histochem Cell Biol ; 116(4): 337-48, 2001 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-11702192

RESUMEN

Both epidermal growth factor (EGF) and the extracellular matrix components have been implicated in the pathobiology of adenocarcinomas by somewhat poorly understood mechanisms. We have addressed this problem using an in vitro model comprising the colon adenocarcinoma cell line HT29-D4, wherein the role of EGF and type IV collagen on cell adhesion was examined. We demonstrated that the effect of EGF on HT29-D4 cell adhesion was regulated by type IV collagen in a time- and dose-dependent manner. The incorporation of a panel of monoclonal antibodies to integrins alpha1beta1, alpha2beta1 and alpha3beta1 in adhesion medium revealed that EGF-mediated increase in the cell adhesion was mediated essentially by alpha2beta1, and the use of flow cytometry led us to conclude that this EGF effect was mediated by an increase in alpha2beta1 activation and not by an increase in cell surface expression of integrin. An indirect immunofluorescence technique was employed to demonstrate that focal adhesion kinase (FAK) and alpha2beta1 integrin were present in focal complexes in large EGF-induced lamellipodia whereas actin cytoskeleton was organised in small tips that colocalised with FAK. This pattern was observed at early time points (15 min) with a strong FAK tyrosine phosphorylation and with an increase in mitogen-activated protein kinase activity (5-15 min) as measured by immunoprecipitation and immunoblotting. We conclude that at early time points of cell adhesion and spreading, EGF exerted an inside-out regulation of alpha2beta1 integrin in HT29-D4 cells. This regulation seemed to be mediated by EGF-dependent FAK phosphorylation entailing an increase in integrin activation and their recruitment in numerous focal complexes. Furthermore after activation, FAK induced aggregation of actin-associated proteins (paxillin, vinculin and other tyrosine phosphorylated proteins) in focal complexes, leading to organisation of actin cytoskeleton that is involved in lamellipodia formation. Finally, activated alpha2beta1 integrins intervened in all these processes clustered in small focal complexes but not in focal adhesions.


Asunto(s)
Actinas/efectos de los fármacos , Adhesión Celular/efectos de los fármacos , Movimiento Celular/efectos de los fármacos , Factor de Crecimiento Epidérmico/farmacología , Integrinas/fisiología , Proteínas Tirosina Quinasas/metabolismo , Actinas/metabolismo , Anticuerpos Monoclonales/farmacología , Calcio/metabolismo , Colágeno Tipo IV/farmacología , Citoesqueleto/efectos de los fármacos , Citoesqueleto/metabolismo , Relación Dosis-Respuesta a Droga , Receptores ErbB/metabolismo , Citometría de Flujo , Técnica del Anticuerpo Fluorescente Indirecta , Quinasa 1 de Adhesión Focal , Proteína-Tirosina Quinasas de Adhesión Focal , Células HT29/citología , Células HT29/efectos de los fármacos , Células HT29/metabolismo , Humanos , Immunoblotting , Integrinas/inmunología , Integrinas/metabolismo , Proteína Quinasa 1 Activada por Mitógenos/metabolismo , Proteína Quinasa 3 Activada por Mitógenos , Proteínas Quinasas Activadas por Mitógenos/metabolismo , Fosforilación/efectos de los fármacos , Receptores de Colágeno , Factores de Tiempo , Tirosina/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA